跳至主要内容
临床试验/ISRCTN40814031
ISRCTN40814031已完成3 期

Radiotherapy and Androgen Deprivation In Combination After Local Surgery

MRC Clinical Trials Unit at UC0 个研究点目标入组 4,236 人开始时间: 2006年10月31日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
4,236

研究概览

简要总结

2007 Protocol article in http://www.ncbi.nlm.nih.gov/pubmed/17359901 protocol 2022 Abstract results in https://oncologypro.esmo.org/meeting-resources/esmo-congress/duration-of-androgen-deprivation-therapy-adt-with-post-operative-radiotherapy-rt-for-prostate-cancer-first-results-of-the-radicals-hd-trial-i RADICALS-HD (added 08/12/2022) 2020 Other publications in https://pubmed.ncbi.nlm.nih.gov/33002431/ (added 08/12/2022) 2022 Other publications in https://pubmed.ncbi.nlm.nih.gov/35810050/ RADICALS-HD (added 08/12/2022) 2020 Results article in https://pubmed.ncbi.nlm.nih.gov/33002429/ RADICALS-RT (added 08/12/2022) 2024 Results article in https://doi.org/10.1016/s0140-6736(24)00548-8 RADICALS-HD (added 20/05/2024) 2024 Results article in https://doi.org/10.1016/s0140-6736(24)00549-x RADICALS-HD (added 20/05/2024)

研究设计

研究类型
Interventional

入排标准

性别
Male

入选标准

  • Patient has undergone radical prostatectomy

排除标准

  • 1. Androgen deprivation prior to radical prostatectomy
  • 2. Bilateral orchidectomy
  • 3. Prior pelvic radiotherapy
  • 4. Other active malignancy likely to interefere with protocol treatment or follow-up
  • 5. Known distant metastases from prostate cancer

研究者

发起方
MRC Clinical Trials Unit at UC

相似试验

进行中(未招募)
1 期
Radiotherapy and Androgen Deprivation in Combination After Local Surgery. A randomised controlled trial for patients with prostate cancer.MedDRA version: 20.0Level: PTClassification code 10060862Term: Prostate cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Prostate Cancer
EUCTR2006-000205-34-IEniversity College London4,000
进行中(未招募)
1 期
Radiotherapy and Androgen Deprivation in Combination After Local Surgery. A randomised controlled trial for patients with prostate cancer.MedDRA version: 20.0Level: PTClassification code 10060862Term: Prostate cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Prostate Cancer
EUCTR2006-000205-34-DKniversity College London4,000
进行中(未招募)
1 期
Radiotherapy and Androgen Deprivation in Combination After Local Surgery. A randomised controlled trial for patients with prostate cancer.MedDRA version: 20.0 Level: PT Classification code 10060862 Term: Prostate cancer System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Prostate Cancer
EUCTR2006-000205-34-GBniversity College London4,000
进行中(未招募)
1 期
Addition of Apalutamide to current standard therapy (hormonal therapy and radiation therapy) in patients with prostate cancer.
EUCTR2018-000899-15-PLEuropean Organisation for Research and Treatment of Cancer (EORTC)990
进行中(未招募)
1 期
Addition of Apalutamide to current standard therapy (hormonal therapy and radiation therapy) in patients with prostate cancer.Intermediate and Limited High Risk Localized Prostate CancerMedDRA version: 20.0Level: PTClassification code 10060862Term: Prostate cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
EUCTR2018-000899-15-BEEuropean Organisation for Research and Treatment of Cancer (EORTC)990